These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19245313)

  • 1. Assessment of the use of urine samples to detect colonization with fluoroquinolone-susceptible and fluoroquinolone-resistant Escherichia coli.
    Lautenbach E; Babson A; Santana E; Tolomeo P; Black N; Smith CA; Maslow J
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):396-7. PubMed ID: 19245313
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility.
    Maslow JN; Lee B; Lautenbach E
    Emerg Infect Dis; 2005 Jun; 11(6):889-94. PubMed ID: 15963284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray.
    Yu X; Susa M; Weile J; Knabbe C; Schmid RD; Bachmann TT
    Int J Med Microbiol; 2007 Oct; 297(6):417-29. PubMed ID: 17482874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities.
    Han JH; Maslow J; Han X; Xie SX; Tolomeo P; Santana E; Carson L; Lautenbach E
    J Infect Dis; 2014 Feb; 209(3):420-5. PubMed ID: 23986544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient recovery of fluoroquinolone-susceptible and fluoroquinolone-resistant Escherichia coli strains from frozen samples.
    Lautenbach E; Santana E; Lee A; Tolomeo P; Black N; Babson A; Perencevich EN; Harris AD; Smith CA; Maslow J
    Infect Control Hosp Epidemiol; 2008 Apr; 29(4):367-9. PubMed ID: 18279070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.
    Lautenbach E; Metlay JP; Mao X; Han X; Fishman NO; Bilker WB; Tolomeo P; Wheeler M; Nachamkin I
    Clin Infect Dis; 2010 Aug; 51(3):280-5. PubMed ID: 20597679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonization with extraintestinal pathogenic Escherichia coli among nursing home residents and its relationship to fluoroquinolone resistance.
    Maslow JN; Lautenbach E; Glaze T; Bilker W; Johnson JR
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3618-20. PubMed ID: 15328142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
    J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.
    Lautenbach E; Harris AD; Perencevich EN; Nachamkin I; Tolomeo P; Metlay JP
    Antimicrob Agents Chemother; 2005 Feb; 49(2):798-800. PubMed ID: 15673772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance.
    Piatti G; Mannini A; Balistreri M; Schito AM
    J Clin Microbiol; 2008 Feb; 46(2):480-7. PubMed ID: 18057134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection.
    Johnson JR; Kuskowski MA; Owens K; Clabots C; Singer RS
    Vet Microbiol; 2009 Apr; 136(1-2):108-14. PubMed ID: 19019576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
    Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections.
    Yasufuku T; Shigemura K; Shirakawa T; Nakano Y; Tanaka K; Arakawa S; Kinoshita S; Nishimura K; Kawabata M; Fujisawa M
    Scand J Infect Dis; 2011 Feb; 43(2):83-8. PubMed ID: 20942776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess body weight and age associated with the carriage of fluoroquinolone and third-generation cephalosporin resistance genes in commensal Escherichia coli from a cohort of urban Vietnamese children.
    Thi Quynh Nhi L; Thanh Tuyen H; Duc Trung P; Do Hoang Nhu T; Duy PT; Hao CT; Thi Thanh Nhan N; Vi LL; Thi Diem Tuyet H; Thi Thuy Tien T; Van Vinh Chau N; Khanh Lam P; Thwaites G; Baker S
    J Med Microbiol; 2018 Oct; 67(10):1457-1466. PubMed ID: 30113307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli.
    Longhi C; Marazzato M; Conte MP; Iebba V; Schippa S; Seganti L; Comanducci A
    J Antibiot (Tokyo); 2009 Feb; 62(2):109-11. PubMed ID: 19198637
    [No Abstract]   [Full Text] [Related]  

  • 17. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli.
    Han JH; Garrigan C; Johnston B; Nachamkin I; Clabots C; Bilker WB; Santana E; Tolomeo P; Maslow J; Myers J; Carson L; Lautenbach E; Johnson JR;
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):275-280. PubMed ID: 27939288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital.
    Lautenbach E; Tolomeo P; Mao X; Fishman NO; Metlay JP; Bilker WB; Nachamkin I
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3939-43. PubMed ID: 16982789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.
    Sorlozano A; Gutierrez J; Jimenez A; de Dios Luna J; Martínez JL
    J Clin Microbiol; 2007 Aug; 45(8):2740-2. PubMed ID: 17567787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.